Francis Couturaud, MD, PhD; Olivier Sanchez, MD, PhD; Gilles Pernod, MD, PhD; et al.
free access
has audio
JAMA. 2015;314(1):31-40. doi:10.1001/jama.2015.7046
This randomized trial compared the efficacy and safety of 6 vs 24 months of warfarin treatment for preventing recurrent thromboembolism in patients with a first episode of symptomatic unprovoked pulmonary embolism.
-
Podcast:
Duration of Oral Anticoagulation After PE
Deborah A. Levine, MD, MPH; Andrzej T. Galecki, MD, PhD; Kenneth M. Langa, MD, PhD; et al.
free access
has multimedia
has audio
JAMA. 2015;314(1):41-51. doi:10.1001/jama.2015.6968
This prospective cohort study reports that incident stroke among participants aged 45 years or older without cognitive impairment was associated with acute decline in cognitive function and also accelerated and persistent cognitive decline over 6 years.
-
Podcast:
Trajectory of Cognitive Decline After Incident Stroke
-
Editorial
Stroke and Cognitive Decline
Philip B. Gorelick, MD, MPH; David Nyenhuis, PhD
JAMA
The Emerging Risk Factors Collaboration
free access
JAMA. 2015;314(1):52-60. doi:10.1001/jama.2015.7008
This study uses individual participant data from the Emerging Risk Factors Collaboration to estimate reductions in life expectancy associated with cardiometabolic multimorbidity.
Seyedeh Ghazaleh Dashti, DDS, MPH; Rowena Chau, PhD, MPH; Driss Ait Ouakrim, PhD, MPH; et al.
free access
JAMA. 2015;314(1):61-71. doi:10.1001/jama.2015.6789
Using colon cancer registry data, these investigators found that in women with a mismatch repair gene mutation, hormonal factors such as age at menarche, parity, and use of hormonal contraceptives were associated with a lower risk of endometrial cancer.